ScreenPoint was founded in 2014 as a spin-off from Radboud University Medical Center in Nijmegen, The Netherlands, to develop and bring to the market innovative machine learning solutions to improve breast cancer screening and diagnosis. With an exceptional team of specialists in machine learning, image analysis, and breast imaging, ScreenPoint developed the market leading AI solution Transpara for reading mammograms and breast tomosynthesis. Clinical studies demonstrate that the FDA cleared software matches experienced radiologists in detecting breast cancer and allows them to improve quality and efficiency of breast cancer screening. Transpara is already used in over 200 clinics in 23 countries. ScreenPoint is focussing on extending its AI solutions for breast healthcare to enable radiologists to deliver the highest quality in an environment that is increasingly demanding.